metabolic profiling of Parkinson's disease and mild cognitive impairment

Background: Early diagnosis of Parkinson's disease and mild cognitive impairment is important to enable prompt treatment and improve patient welfare, yet no standard diagnostic test is available. Metabolomics is a powerful tool used to elucidate disease mechanisms and identify potential biomark...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mov Disord
Главные авторы: Burté, Florence, Houghton, David, Lowes, Hannah, Pyle, Angela, Nesbitt, Sarah, Yarnall, Alison, Yu‐Wai‐Man, Patrick, Burn, David J., Santibanez‐Koref, Mauro, Hudson, Gavin
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2017
Предметы:
Brief Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485028/
https://ncbi.nlm.nih.gov/pubmed/28394042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26992
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы